Trump administration investigating admission policies at some medical schools

Published 03/26/2026, 01:54 PM
Updated 03/27/2026, 10:19 AM
Trump administration investigating admission policies at some medical schools

By Ryan Patrick Jones and Kanishka Singh

WASHINGTON, March 26 (Reuters) - The Trump administration has opened investigations into admissions policies at some major medical schools, marking its latest crackdown against top U.S. educational institutions.

The investigation would focus on "possible race discrimination in medical school admissions," Assistant Attorney General for Civil Rights Harmeet Dhillon told the schools in letters. Dhillon confirmed the probes in a post on X on Thursday.

Medical schools at Ohio State University, the University of California, San Diego, and Stanford University said on Thursday they were notified about the federal probes first reported by the New York Times. Ohio State University shared with Reuters the letter that it got and which was dated Wednesday.

President Donald Trump has threatened to withhold federal funds from universities over issues including pro-Palestinian protests against Israel’s assault on Gaza, diversity initiatives, climate programs and transgender policies.

The government’s crackdown has been criticized over concerns that it curbs academic freedom, free speech and due process, while its efforts to freeze funds have faced ​legal and judicial roadblocks.

The administration has in particular launched multiple investigations and lawsuits focusing on whether universities consider race in admissions after the U.S. Supreme Court’s 2023 ruling that ended affirmative action in higher education.

Education advocates have urged universities to push back against government efforts to collect more admissions data, saying they could lead to privacy violations.

In its latest probes, the government is seeking information about medical school applicants from each of the past seven years, including test scores and home zip codes, as well as copies of internal university messages about diversity, equity and inclusion and correspondence between school officials and pharmaceutical companies about admissions policies.

The government demanded the schools provide the data by April 24, the letter says.

UC San Diego said it was notified by the Justice Department that it had commenced a probe and that the school was reviewing the notice. It added that the school was committed to fair processes in its programs, including admissions, in line with federal and state anti-discrimination laws.

The University of California system, of which UC San Diego is a part, has been repeatedly attacked by the Trump administration during his second term in office.

Ohio State University said it was fully compliant with state and federal laws and rulings, and would "respond appropriately" to the government.

Stanford School of Medicine said it was reviewing the letter and that the school prohibits "unlawful discrimination on the basis of race, color, national or ethnic origin, or any other characteristic protected by applicable law."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.